Items where authors include "de Wit, R."

Article

Srivastava, T., Prabhu, V.S., Li, H. et al. (7 more authors) (2020) Cost-effectiveness of pembrolizumab as second-line therapy for the treatment of locally advanced or metastatic urothelial carcinoma in Sweden. European Urology Oncology, 3 (5). pp. 663-670. ISSN 2588-9311